General Information

The ISN Clinical Practice Guidelines Committee (CPGC) was established in 2004 to address the ever-increasing number of guidelines being issued by various organizations and entities around the world. It was also formed due to the fact that ISN had been approached repeatedly — as the international society — for comments on (and endorsement of) guidelines.

Activities

It is not the intention of ISN to develop its own guidelines; however — through its Clinical Practice Guidelines Committee — ISN undertakes the following:

• Evaluation of guidelines with particular emphasis on their impact on local practice.
• Formulation of recommendations back to the organizations issuing guidelines.
• Encouragement to develop guidelines focused on areas of unmet need.
• Endorsement of guidelines.

Endorsed Guidelines:
This section contains guidelines that meet the approval or receive the endorsement of ISN. These guidelines are produced or endorsed by a national or regional medical or health organization, professional society, government agency or expert panel.

KDIGO:
View the ISN Clinical Practice Guidelines Committee’s Position Statement on the Definition and Classification of Chronic Kidney Disease issued by Kidney Disease: Improvement of Global Outcomes (KDIGO).

Committee Membership (January 2008 – January 2011)

Chair: Gavin Becker (Australia) [email protected]

Omar Abboud (Sudan)
Ezekiel Bellorin Font (Venezuela)
Michael Field (Australia)
Richard Johnson (USA)
Philip Li (China)
Christoph Wanner (Germany)